These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1765988)

  • 1. Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association.
    Hedin PJ; Weitoft T; Hedin H; Engström-Laurent A; Saxne T
    J Rheumatol; 1991 Oct; 18(10):1601-5. PubMed ID: 1765988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis.
    Kida D; Yoneda M; Miyaura S; Ishimaru T; Yoshida Y; Ito T; Ishiguro N; Iwata H; Kimata K
    J Rheumatol; 1999 Jun; 26(6):1230-8. PubMed ID: 10381035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
    Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
    Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers of systemic disease processes in osteoarthritis.
    Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
    J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage proteoglycan aggrecan as a predictor of joint damage in juvenile rheumatoid arthritis.
    el-Sayed ZA; Saleh MT; Al-Wakkad AS; Sherief LS; Nasr el-Din AM
    East Mediterr Health J; 2001 Nov; 7(6):992-1003. PubMed ID: 15332741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum hyaluronic acid and aminoterminal procollagen III peptide in inflammatory and degenerative joint diseases].
    Seibel MJ; Raimann S; Seglias J; Lautenschläger J; Müller W
    Z Rheumatol; 1988; 47(2):98-106. PubMed ID: 3388993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
    Manicourt DH; Poilvache P; Nzeusseu A; van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 1999 Sep; 42(9):1861-9. PubMed ID: 10513800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecular markers in joint disease.
    Heinegård D; Saxne T
    J Rheumatol Suppl; 1991 Feb; 27():27-9. PubMed ID: 2027121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum keratan sulfate studies and their significance in the evaluation of cartilage degradation in degenerative and inflammatory joint diseases].
    Sárközi AM; Hámori G; Fülöp C; Búzás E; Brózik M; Merétey K; Glant TT
    Orv Hetil; 1993 Feb; 134(9):461-7. PubMed ID: 8446416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.
    Urakami T; Manki A; Inoue T; Oda M; Tanaka H; Morishima T
    J Rheumatol; 2006 May; 33(5):996-1000. PubMed ID: 16652429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis.
    Kang Y; Eger W; Koepp H; Williams JM; Kuettner KE; Homandberg GA
    J Orthop Res; 1999 Nov; 17(6):858-69. PubMed ID: 10632453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.